SAPHO syndrome treatment with intravenous pamidronate: Retrospective study of 22 patients

Joint Bone Spine

Volumn 81, Issue 5, 2014, Pages 456-458

  Delattre, Émilie ^a   Guillot, Xavier ^a   Godfrin Valnet, Marie ^a   Prati, Clément ^a   Wendling, Daniel ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Bisphosphonates; Pamidronate; SAPHO; Treatment

Indexed keywords

PAMIDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPEROSTOSIS; HYPERTHERMIA; HYPOCALCEMIA; LABORATORY TEST; LETTER; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OSTEITIS; RETROSPECTIVE STUDY; RISK FACTOR; SACROILIAC JOINT; SAPHO SYNDROME; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN DISEASE; VISUAL ANALOG SCALE; ACQUIRED HYPEROSTOSIS SYNDROME; INTRAVENOUS DRUG ADMINISTRATION; VERY ELDERLY;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84927696666     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2014.01.017     Document Type: Letter

References (7)

1. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 1988, 6:109-112.
2. Hayem G., Bouchaud-Chabot A., Benali K., et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999, 29:159-171.
3. Amital H., Applbaum Y.H., Aamar S., et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 2004, 43:658-661.
4. Kerrison C., Davidson J.E., Cleary A.G., et al. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology 2004, 43:1246-1251.
5. Valls-Roc M., Sanmarti M., Salles M., et al. SAPHO syndrome and pamidronate revisited. Rheumatology 2005, 44:137.
6. Solau-Gervais E., Soubrier M., Gerot I., et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology 2006, 45:339-342.
7. Colina M., La Corte R., Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009, 27:112-115.